Provided by Tiger Trade Technology Pte. Ltd.

Century Therapeutics, Inc.

2.07
+0.05002.48%
Post-market: 2.130.0600+2.90%19:30 EDT
Volume:330.59K
Turnover:680.42K
Market Cap:374.67M
PE:-2.23
High:2.09
Open:2.05
Low:2.02
Close:2.02
52wk High:3.04
52wk Low:0.4350
Shares:181.00M
Float Shares:101.00M
Volume Ratio:0.80
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-0.1107
ROE:-49.65%
ROA:-23.51%
PB:1.61
PE(LYR):-18.70

Loading ...

Century Therapeutics Q1 Operating Income USD -23.684 Million

THOMSON REUTERS
·
May 13

Press Release: Century Therapeutics Reports First Quarter Financial Results and Business Updates

Dow Jones
·
May 13

Century Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 01

Century Therapeutics to give oral presentation of CNTY-813 preclinical data at ADA Scientific Sessions

Reuters
·
May 01

Century Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 21

Century Therapeutics price target raised to $5 from $2 at H.C. Wainwright

TIPRANKS
·
Apr 21

Century Therapeutics director Martin Patrick Murphy files initial beneficial ownership statement

Reuters
·
Apr 11

Corrected-Century Therapeutics Inc - Sold $18.4 Mln in Common Stock Through TD Cowen - SEC Filing (Not 'May Offer $150 Mln')

THOMSON REUTERS
·
Mar 27

Century Therapeutics Updates ATM Program to Enhance Liquidity

TIPRANKS
·
Mar 27

Century Therapeutics updates $150.0 million ATM program; $131.6 million remains available for sale

Reuters
·
Mar 27

Century Therapeutics Inc - May Offer up to $150 Mln in Common Stock Through TD Cowen - SEC Filing

THOMSON REUTERS
·
Mar 27

Century Therapeutics Rocked by Dual Insider Moves at the Top

TIPRANKS
·
Mar 17

Century Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 12

Century Therapeutics Reports 2025 Results and Pipeline Progress

TIPRANKS
·
Mar 12

Century Therapeutics Q4 EPS $(0.25) Beats $(0.27) Estimate

Benzinga Earnings
·
Mar 12

Century Therapeutics 2025 net loss narrows beating estimates

Reuters
·
Mar 12

Century Therapeutics FY2025 net loss narrows 92% to USD 9.58 million on collaboration revenue of USD 109.16 million

Reuters
·
Mar 12

BRIEF-Century Therapeutics FY Net Income USD -9.58 Million

Reuters
·
Mar 12

Century Therapeutics FY Operating Expenses USD 126.433 Million

THOMSON REUTERS
·
Mar 12

Century Therapeutics Inc - Cnty-813 Ind Submission Expected in Q4 2026; Initial Clinical Data Anticipated in 2H 2027

THOMSON REUTERS
·
Mar 12